BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18686944)

  • 1. Assessing how well a modeling protocol captures a structure-activity landscape.
    Guha R; Van Drie JH
    J Chem Inf Model; 2008 Aug; 48(8):1716-28. PubMed ID: 18686944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR modeling using chirality descriptors derived from molecular topology.
    Golbraikh A; Tropsha A
    J Chem Inf Comput Sci; 2003; 43(1):144-54. PubMed ID: 12546547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure--activity landscape index: identifying and quantifying activity cliffs.
    Guha R; Van Drie JH
    J Chem Inf Model; 2008 Mar; 48(3):646-58. PubMed ID: 18303878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship modeling of the toxicity of organothiophosphate pesticides to Daphnia magna and Cyprinus carpio.
    Zvinavashe E; Du T; Griff T; van den Berg HH; Soffers AE; Vervoort J; Murk AJ; Rietjens IM
    Chemosphere; 2009 Jun; 75(11):1531-8. PubMed ID: 19376559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation.
    Basak SC; Mills D; Hawkins DM; Kraker JJ
    Chem Biodivers; 2009 Apr; 6(4):487-502. PubMed ID: 19353545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget structure-activity relationships characterized by activity-difference maps and consensus similarity measure.
    Medina-Franco JL; Yongye AB; Pérez-Villanueva J; Houghten RA; Martínez-Mayorga K
    J Chem Inf Model; 2011 Sep; 51(9):2427-39. PubMed ID: 21842860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local lazy regression: making use of the neighborhood to improve QSAR predictions.
    Guha R; Dutta D; Jurs PC; Chen T
    J Chem Inf Model; 2006; 46(4):1836-47. PubMed ID: 16859315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
    Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
    J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR study for mycobacterial promoters with low sequence homology.
    González-Díaz H; Pérez-Bello A; Uriarte E; González-Díaz Y
    Bioorg Med Chem Lett; 2006 Feb; 16(3):547-53. PubMed ID: 16275068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity.
    Holder AJ; Ye L
    Dent Mater; 2009 Jan; 25(1):20-5. PubMed ID: 18584863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the domain of applicability in QSAR modeling.
    Weaver S; Gleeson MP
    J Mol Graph Model; 2008 Jun; 26(8):1315-26. PubMed ID: 18328754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives.
    Pérez-Villanueva J; Santos R; Hernández-Campos A; Giulianotti MA; Castillo R; Medina-Franco JL
    Bioorg Med Chem; 2010 Nov; 18(21):7380-91. PubMed ID: 20888242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.